This document outlines recommendations for developing and implementing an antibiotic policy in hospitals. It discusses formulating the policy based on local antimicrobial susceptibility data. The policy should include guidelines for empiric, prophylactic, and definitive antibiotic therapy along with restricted and reserve drug lists. It recommends establishing an antibiotic management team to monitor implementation and assess outcomes, such as antibiotic consumption. Regular review and updating of the policy based on new clinical and susceptibility data is also advised. The overall goal is to optimize antibiotic use and slow the development of antimicrobial resistance.
Antibiotics are most common therapeutic agents used in hospitals across world, however, microbial world is becoming resistant day by day, posing special challenges to clinicians specially working in ICU set ups. There are multiple ways to curb this menace, if approached together in antibiotic stewardship way, can bring about wonders and retain therapeutic potentials of these drugs.
Antibiotics are most common therapeutic agents used in hospitals across world, however, microbial world is becoming resistant day by day, posing special challenges to clinicians specially working in ICU set ups. There are multiple ways to curb this menace, if approached together in antibiotic stewardship way, can bring about wonders and retain therapeutic potentials of these drugs.
Antibiotic policy and trends in antibiotic policy,
References
Infection control: Basic concepts and practices, 2nd edn.
www.cdc.org
Antibiotics guide: choices for common infections
Chennai Declaration
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...John Blue
Antimicrobial Use and Stewardship in the Pediatric Outpatient Setting - Dr. Theoklis Zaoutis, Chief, Division of Infectious Diseases, Professor of Pediatrics and Epidemiology of the University of Pennsylvania, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Antibiotic policy and trends in antibiotic policy,
References
Infection control: Basic concepts and practices, 2nd edn.
www.cdc.org
Antibiotics guide: choices for common infections
Chennai Declaration
Dr. Theoklis Zaoutis - Antimicrobial Use and Stewardship in the Pediatric Out...John Blue
Antimicrobial Use and Stewardship in the Pediatric Outpatient Setting - Dr. Theoklis Zaoutis, Chief, Division of Infectious Diseases, Professor of Pediatrics and Epidemiology of the University of Pennsylvania, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
The New War on Bugs: Crafting an Effective Antibiotic Stewardship Program
More than half of all hospital patients are treated with antibiotics and prescribing practices vary widely, even within hospitals. Efforts to rationalize antibiotic use have been stymied by delays in obtaining specific diagnoses, by the volume of prescriptions written each day and by the difficulty of extracting meaningful data from scattered clinical, laboratory and pharmacy records. But the push is on – from the White House, the CDC, infectious disease specialists, the industry – for more judicious use of antibiotics through antibiotic stewardship programs.
Hear how leading health care institutions have moved from education to active surveillance to intervention, reducing infections and lowering costs.
Advisor Live: Antimicrobial Stewardship - Why Now and How?Premier Inc.
This 90-minute webinar discusses strategies and tools for implementing antimicrobial stewardship programs, including methods for measuring antimicrobial use and resistance.
Join Premier’s free Advisor Live® webinar series for a special Get Smart About Antibiotics Week presentation on Thursday, November 19 from 12-1:30 p.m. EST. The panel for this 90-minute webinar will discuss strategies and tools for implementing antimicrobial stewardship programs, including methods for measuring antimicrobial use and resistance.
EXPERT PRESENTERS:
- Gina Pugliese, RN, MS, vice president, Premier Safety Institute®, moderator
- Arjun Srinivasan, MD, (CAPT, USPHS) medical director of the CDC’s Get Smart for Healthcare program, will highlight the national focus on antibiotic stewardship and reasons for the current urgency
- Michael Postelnick, RPh, BCPS AQ- Infectious Diseases, clinical manager and senior infectious diseases pharmacist for Northwestern Memorial Hospital, will share lessons learned from implementing their antibiotic stewardship program
- Craig Barrett, Pharm.D., BCPS, director safety solutions for Premier, Inc. will share strategies from Premier member hospitals striving for antimicrobial stewardship
Dr. Lauri Hicks - Out-Patient Antibiotic Resistance (AMR) IssuesJohn Blue
Out-Patient Antibiotic Resistance (AMR) Issues - Dr. Lauri Hicks, Commander, U.S. Public Health Service, Medical Epidemiologist, Respiratory Diseases Branch; Medical Director, Get smart: Know When Antibiotic Work Program; Centers for Disease Control and Prevention (CDC), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
Advisor Live: Advancing Antimicrobial StewardshipPremier Inc.
Fight antibiotic resistance! Join us and participate in Get Smart About Antibiotics Week 2016. Medical epidemiologist Dr. Kavita Trivedi will share her deep wealth of knowledge to help your organization implement and meet the challenges of antimicrobial stewardship.
- Current regulatory environment
- Implementation tools available
- Implementation challenges
Dr. Beth Bell - CDC’s Overall Effort on Antibiotics, FY 2015 Requested Fundin...John Blue
CDC’s Overall Effort on Antibiotics, FY 2015 Requested Funding and CARB Program - Dr. Beth Bell, Director of the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
Antibiotic Guardian Birmingham Workshop4 All of Us
Antibiotic resistance is one of the biggest threats facing us today!
European Antibiotic Awareness Day (EAAD) is part of the UK 5 Year Antimicrobial Resistance Strategy 2013 to 2018, which focuses on antibiotics and sets out actions to slow the development and spread of antimicrobial resistance.
This year, to run in line with EAAD; Public Health England has established the Antibiotic Guardian pledge campaign. It calls on everyone in the UK, the public and healthcare community to become antibiotics guardian by choosing one simple pledge about how they will make better use of these vital medicines.
To ensure that the information and knowledge on Antibiotic Stewardship is disseminated to those practising healthcare across the nation, a series of awareness and educational events have been developed. These educational workshop events, to be held in Leeds, Birmingham and London, will provide guidance, resources and information for practitioners on topics associated with antibiotic awareness. The events will provide an opportunity to understand how you and your organisation can support combat the global challenge faced by antibiotic resistance whilst gaining advice, support and resources to inform patients and staff.
Antibiotic Guardian London Workshop 20164 All of Us
Antibiotic resistance is one of the biggest threats facing us today.
Why it is relevant to you: without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.
What we want you to do: To slow resistance we need to cut the unnecessary use of antibiotics. We invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians.
Call to action: Choose one simple pledge about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
Antimicrobial resistance is one of the biggest threats to human health and is rising to dangerously high levels in all parts of the world. Anyone, of any age, in any country, could be impacted. While it's normal for microbes to develop resistance to drugs, the way antimicrobials are currently being used is accelerating the process, and as a result common infections and minor injuries are becoming an increasingly greater threat to our well-being. Organizations from across the world are taking action and making progress on this issue, but is there anything patients, their families and patient advisors can do to help?
See the full presentation here: https://goo.gl/AYCsdd
Dr.sherin elsherbiny
Senior registrar clinical microbiology
AMR coordinator
Infection control auditor
Riyadh region
Meeqat General Hospital ,Madina,KSA
CDC Key Prevention Strategies for Antimicrobial Resistance Prevent Infection Step 1: Vaccinate Fact:
Influenza and pneumococcal vaccination of at-risk hospital patients and influenza vaccination of healthcare personnel will prevent infections.
Step 2: Get the catheters out Fact:
Catheters and other invasive devices are the # 1 exogenous cause of hospital-onset infections.
Diagnose & Treat Infection Effectively Step 3: Target the pathogen
Fact:
Appropriate antimicrobial therapy saves lives.
Step 4: Access the experts Fact:
Infectious diseases expert input improves the outcome of serious infections.
•
Use Antimicrobials Wisely
Step 5: Practice antimicrobial control Fact:
Programs to improve antimicrobial use are effective. (Antimicrobial Stewardship)
•
Step 6: Use local data
Fact:
The prevalence of resistance can vary by locality, patient population, hospital unit, and length of stay.
•
•
Step 7: Treat infection, not contamination Fact:
A major cause of antimicrobial overuse is “treatment” of contaminated cultures.
Step 8: Treat infection, not colonization Fact:
Step 9: Know when to say “no” to vancomycin Fact:
Vancomycin overuse promotes emergence, selection,and spread of resistant pathogens.
•
Step 10: Stop antimicrobial treatment Fact:
Failure to stop unnecessary antimicrobial treatment contributes to overuse and resistance.
Prevent Transmission
Step 11: Isolate the pathogen Fact:
Patient-to-patient spread of pathogens can be prevented.
•
Step 12: Break the chain of infection Fact:
Healthcare personnel can spread antimicrobial-resistant pathogens from patient to patient
Antimicrobial stewardship; is an activity that includes appropriate selection, dosing, route, and duration of antimicrobial therapy…..
Why is Antimicrobial Stewardship Important?
200-300 million antibiotics are prescribed annually….45% for outpatient use
25-40% of hospitalized patients receive antibiotics
10-70% are unnecessary or suboptimal
5% of hospitalized patients who receive antibiotics experience an Adverse reaction.
Health insurance companies will no longer reimburse for hospital acquired conditions deemed preventable.
Why is an antibiotic policy necessary?
To improve patient care by considered use of antibiotics for prophylaxis and therapy.
To rationalize the use of antibiotics.
To prevent or retard the emergence of resistant strains.
To improve education of junior doctors by providing guidelines for appropriate therapy
What are the clinical uses of antibiotics :
1. Therapeutic use:-
It is administration of an antimicrobial agent where substantial microbial infection has occurred.
2. Prophylactic Use:-
It is the use of antimicrobial agent before any infection has occurred to prevent a subsequent infection.
The Antimicrobial Stewardship Program (ASP) should be administered by multidisciplinary team (AST) composed of:
an infectious diseases (ID)physician
a clinical pharmacist with ID training,
a clinical microbiologist,
an IC professional,
Antibioti
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Dr. Jeff Bender - Companion Animal Antimicrobial StewardshipJohn Blue
Companion Animal Antimicrobial Stewardship - Dr. Jeff Bender, Co-Director for the Upper Midwest Agricultural Safety and Health Center and Professor College of Veterinary Medicine and School of Public Health at the University of Minnesota, Chair for the AVMA Task Force for Antimicrobial Stewardship in companion Animal Practice, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
For decades microbes, in particular bacteria, have become increasingly resistant to various antimicrobials.
The World Health Assembly’s endorsement of the Global Action Plan on Antimicrobial Resistance (AMR) in May 2015, and the Political Declaration of the High-Level Meeting of the General Assembly on AMR in September 2017, both recognize AMR as a global threat to public health.
These policy initiatives acknowledge overuse and misuse of antimicrobials as a main driver for development of resistance, as well as a need to optimize the use of antimicrobials.
The Global Action Plan on AMR sets out five strategic objectives as a blueprint for countries in developing national action plans (NAPs) on AMR:
Objective 1: Improve awareness and understanding of AMR through effective communication, education and training.
Objective 2: Strengthen the knowledge and evidence base through surveillance and research.
Objective 3: Reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures.
Objective 4: Optimize the use of antimicrobial medicines in human and animal health.
Objective 5: Develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Antimicrobial stewardship programmes optimize the use of antimicrobials, improve patient outcomes, reduce AMR and health-care-associated infections, and save health-care costs amongst others.
Today, AMS is one of three “pillars” of an integrated approach to health systems strengthening. The other two are infection prevention and control (IPC) and medicine and patient safety.
Linking all three pillars to other key components of infection management and health systems strengthening, such as AMR surveillance and adequate supply of quality assured medicines, promotes equitable and quality health care towards the goal of achieving universal health coverage
CDC has defined “Antimicrobial stewardship” as-
The right antibiotic
for the right patient,
at the right time,
with the right dose, and
the right route, causing
the least harm to the patient and future patients
Why AMSP is needed?
Antimicrobial Resistance (AMR)
Misuse and Over-use of Antimicrobials
Widespread Use of Antimicrobials in Other Sectors
Poor Antimicrobial Research
IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM
Administrative Support (Leadership)
Formulating AMS Team
Infrastructure Support
Framing Antimicrobial Policy
Implementing AMS strategies
Education and Training
Should be publicly committed to the program.
Provide necessary funding and infrastructure support.
Multidisciplinary committee - responsible for framing, implementing and monitoring the compliance to antimicrobial policy of the hospital.
Led by the antimicrobial steward - infectious disease physician or infection control officer or clinical microbiologist.
Other members of AMS team - stewardship nurses
6. • Intensive use of antibiotics –
increase prevalence of
resistance
• Due to the selective pressure of antibiotic use
• The modification of the endogenous flora
• Other risk factors:- presence of indwelling devices,
-Exposure to broad spectrum antibiotics and
treatment under dosing,
-Admission to wards where resistant strains are
epidemic or endemic and
-Frequent exposure to nursing and invasive
procedures.
7. Antibiotic Control Programs
Its an ongoing effort by a health care institution to
optimize antimicrobial use among hospitalized patients in
order to improve patient outcomes, ensure cost- effective
therapy, and reduce adverse sequelae of antimicrobial use
8. To recommend specific intervention measures such as
rational use of antibiotics and antibiotic policies in
hospitals which can be implemented as early as possible.
Intervention Measures
• Formulation of antibiotic policies
• Education and training of all prescribers
• Implementation of infection control guidelines
9. • Formulation of an antibiotic policy
• Implementation of an antibiotic policy
• Antibiotic Management Team
• The policy for Presumptive / Empiric therapy
and Prophylactic therapy
• Monitor implementation
• Assess outcome
10. • With quality assured laboratory data in real time
( develop antibiotic policies that are standard national / local
treatment guidelines)
• This must include consideration of spectrum of antibiotics,
pharmacokinetics / pharmacodynamics, adverse effects, cost
and special needs of individual patient groups.
A. Formulation And Implementation of an antibiotic policy
11. o Compile Local Hospital data based on AMR
o Site of infection
o Geographic Variations
(ICUs / Wards / Surgical Site Infections etc.)
o % Distribution of organisms
o %Susceptibility to identified antibiotics
A.1. Formulation-Step I
12. Put the data in given template:
o Site of Infection, Type of Infection.
o Causative pathogens.
o Recent 12 month antimicrobial data.
o Capture pathogens contributing to (80-90)% of infections.
o Capture the susceptibility of antimicrobials from highest to
lowest.
o Pneumonia
o IAI
o UTI
o BSI
o SSTI
o Surgical Prophylaxis.
A.2. Formulation-Step II
13. o Put in database, based on site of infection?
o Data will be separate for Ward and ICU isolates
o 5 most common pathogens be identified and most antibiotics
in decreasing order of sensitivity also be identified.
o Generate the Validity period (X+1yr)
A.3. Formulation-Step III
14. Hospital surveillance data
(Jan- Dec of X year)
Validity of these data: Dec X +1yr
S. No Most Common
Pathogen
%
Prevalence
S. No Most
Sensitive
antibiotics
in
descending
order
1. 1.
2. 2.
3. 3.
4. 4.
5. 5.
16. Type -1 Type-2 Type-3
Health care
contacts
No Yes Prolonged
Procedures No Minimum Major Invasive
procedures
Antibiotic
treatment history
No in last 90 Days Yes in last 90
Days
Repeated multiple
antibiotic
Patient
Characteristic
Young –
No co-morbid
conditions
Elderly few
co-morbid
conditions
Immunocopromised
+/- many co-morbid
condition
Possible causative
pathogen
No MDRs
pathogen
susceptible to
common
antibiotics
ESBLs/MRSA ESBLs+
Pseudomonas+
MRSA
21. The policy for Presumptive / Empiric therapy and
Prophylactic therapy
22. Presumptive/ Empiric antibiotic policy
• should be simple, clear, non-controversial, clinically
relevant, flexible and applicable to day-to-day practice
and available in user friendly format.
• should also include optimal selection dosage, route of
administration, duration, alternatives for allergic to first-line
agents; adjusted dosage for patients with impaired renal
functions.
• Previous history of antimicrobials or current antibiotics
along with patient co morbidities may play a role in final
prescribing.
23. Levels for prescribing antibiotics:
• First choice antibiotics:
Can be prescribed by all doctors
• Restricted list of antibiotics:
Only after permission from HoD or AMT
representative
• Reserve antibiotics: (for life threatening infections)
Only after permission from AMT members
Presumptive therapy only applicable for 48 hrs after that it needs to be
converted into a definitive therapy (de-escalation step) based on evidence
whether clinical or microbiological.
24. Prophylactic Antibiotic Policy
• Procedure for which antibiotic are needed should be posted in
Operating Room with Optimal agents, dosage, timing, route
and duration of administration
e.g. Inj Cefuroxime 1.5 gm I/V before induction of anaesthesia,
repeat another dose if procedure extends beyond 4 hrs.
• should be given for a short duration, free of side effects and
relatively inexpensive and should not be used as a therapy
25. Constructive FEEDBACK of policy prior to implementation
After formulation of the presumptive / empiric & prophylactic
policies they should be circulated to receive constructive
feedback. Policy should be reviewed by respected peers who are
not the members of the AMT, but are also experts in the
relevant field
26. Formulation of an antibiotic policy
Implementation of an antibiotic policy
Antibiotic Management Team
The policy for Presumptive / Empiric therapy and
Prophylactic therapy
• Monitor implementation
• Assess outcome
27. Monitor implementation: we may form Drug and
Therapeutics Committee (DTC)
1. Basis for approval of new drugs:
Based on safety, efficacy, availability and cost of the
medication.
2. Fixing of three brands per approved generic
3. Banning of harmful drugs in the Hospital
(viz. Phenylpropanolamine (PPA), Nimesulide etc)
4. Development of over the counter (OTC) drug list.
This OTC drug list should also contain the quantity to
be dispensed
Which may carry out the following:
28. Assess outcome of Intervention
A monthly update of antibiotic consumption of a unit is
sent with a comparison of other units in the institute this
highlights any excess.
29. Update and Revise
Should be updated EVERY YEAR
(based on local surveillance of antimicrobial susceptibility
data, clinical practice and local circumstances)
30. What India need ?????
“An Implementable antibiotic policy”
and
NOT “ A perfect policy”
31. "A Roadmap to Tackle the Challenge of
Antimicrobial Resistance “
A Joint meeting of Medical Societies in India" was organized
as a pre-conference symposium of the 2 nd annual conference
of the Clinical Infectious Disease Society (CIDSCON 2012) at
Chennai on 24th August.
32.
33. Introduce STEP BY STEP
regulation of antibiotic usage,
concentrating on higher end antibiotics
first and then slowly extending the list to
second and first line antibiotics
36. Conclusion
Although many measures may impact on antimicrobial
resistance, reducing the use of antimicrobials to only those
situations where they are warranted, at the proper dose and
for the proper duration, is the best solution.
Hospitals, as the primary incubators of
antimicrobial-resistant pathogens, carry the highest
responsibility for proper stewardship of our antimicrobial
resources.
37. Florence Nightingale, Notes on Hospitals, 1863
It may seem a strange principle
to enunciate as the very first requirement
of a hospital
that it do the sick no harm
THANK YOU